Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2026-01-01 @ 10:25 PM
Study NCT ID:
NCT05282459
Status:
COMPLETED
Last Update Posted:
2025-03-20
First Post:
2022-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation
Sponsor:
Stanford University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-12
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-03
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-07
First Submit QC Date:
None
Study First Post Date:
2022-03-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-19
Last Update Post Date:
2025-03-20
Last Update Post Date Type:
ACTUAL